OREANDA-NEWS. Cytos Biotechnology Ltd(SIX:"CYTN"; the "Company") holds today a meeting of the Bondholders to vote on the restructuring proposal for the convertible bonds, as announced on 6 January 2015. As the outcome of the meeting is unknown und such outcome may be price sensitive, Cytos has applied with the SIX Swiss Exchange to suspend trading of Cytos' shares as well as Cytos' convertible bonds from ten minutes prior to the start of the meeting (i.e. 12.50 CET)until at least one hour after the outcome of the meeting has been communicated by Cytos in a media release. The SIX Swiss Exchange has approved this request.

About Cytos Biotechnology Ltd

Cytos is a public biopharmaceutical company located in Schlieren (Zurich), Switzerland. The Company is listed according to the Main Standard on the SIX Swiss Exchange Ltd under the symbol CYTN.